Pembrolizumab as Neoadjuvant Treatment in HCC

Clinical trial NCT03337841 · UNKNOWN

Trial details

NCT number: NCT03337841
Sponsor: Kindai University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2017-11-10
Primary completion: 2019-10-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.